The Paradigm of Paragon: Jeff Aronin
Paragon Biosciences is a company that was founded in 2010, with the idea that caring for patients and people could attract companies to fund research to approve life-changing medications for those who need them. This company is run by Mr. Jeff Aronin, a man of great achievement and innovation, who is trying to change the way that healthcare is viewed all around the world. He has been active in the company, and in bettering the world through biological medication for over twenty years. In 2017, he even won the Weizmann Leadership Award for his ability to rally people to this wonderful cause.
Paragon Biosciences follows a three-step pattern to create a successful approach to having new, helpful medicines approved faster.
To begin, the company evaluates a patient and their immediate needs. These needs, according to the Paragon Biosciences’ website, range from narcolepsy, to impending dermatological issues being faced by a large amount of the world population today.
From there, the company identifies and creates medications to assist the needs of their patients. This phase itself is split into a pre-clinical phase, three sub-phases, and then registration for what is assumed to be a clinical trial. Once the medication is tested, phased, and ready to be approved, it is sent to the third and final step.
The final step in the process, and the one that Mr. Aronin himself takes great pride in, would be attracting the funds to help mass amounts of people in an above-average amount of time. This process is done because Mr. Aronin believes that “with 6,000 diseases that have no treatment,” there is no time like the present to begin fighting to fund medication that could bring along advanced treatments, and someday even cures to certain diseases. Once a medication has a sponsor, it can be sent to the FDA more quickly than a traditional company could send the information and get approved much faster.
Overall, Paragon Bioscience and Jeff Aronin are dedicated to finding treatments that suit the individual needs of people and are fighting to get these treatments funded and approved as fast as possible.